Protocol Name: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living with Obesity
Sponsor: Eli Lilly
Indication: CVD and CKD Outcomes in patients with Obesity
Principal Investigator:Bernard Fischbach, MD
Location:Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246